XML 29 R17.htm IDEA: XBRL DOCUMENT

Insider Trading Arrangements

3 Months Ended

Sep. 30, 2025

The following table describes, for the quarterly period covered by this report, each director and officer (as defined in Rule 16a-1(f) under the Exchange Act) who has adopted, modified, or terminated a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act (each plan, a "Rule 10b5-1 Trading Plan"). Each Rule 10b5-1 Trading Plan described below was adopted during an open insider trading window and in accordance with the Company's policies regarding both insider trading and transactions relating to Company securities.

Name

(Title)

Action Taken

(Date of Action)

Rule 10b5-1 Trading Plan Provides for Purchase/Sale

Duration of the Trading Plan(1)

Aggregate Number of Securities

Bradley Campbell

(President & Chief Executive Officer)

Adoption

(September 12, 2025) (2)

Sale

December 31, 2026

Indeterminable(3)

David Clark

(Chief People Officer)

Adoption

(September 10, 2025) (4)

Sale

August 15, 2026

Indeterminable(5)

Ellen Rosenberg

(Chief Legal Officer)

Adoption

(August 27, 2025)(6)

Sale

January 3, 2027

Indeterminable(7)

Jeffrey Castelli

(Chief Development Officer)

Adoption

(August 22, 2025)

Sale

January 31, 2026

76,158(8)

____________________________

(1) The dates in this column represent the scheduled expiration date of each officer’s Rule 10b5-1 Trading Plan. Each Rule 10b5-1 Trading Plan may terminate earlier than the date provided should all transactions contemplated thereunder occur prior to such date.

(2) Trading under Mr. Campbell’s new Rule 10b5-1 Trading Plan may not commence until January 19, 2026, which is after the expiration date of Mr. Campbell’s existing Rule 10b5-1 Trading Plan, adopted on September 13, 2024 (the “Existing Campbell Plan”), and disclosed in the Company’s Quarterly Report on Form 10-Q for the period ending September 30, 2024.

(3) Mr. Campbell’s new Rule 10b5-1 Trading Plan provides for the (i) sale of 90,000 shares of common stock which have been obtained from the vesting of restricted stock unit (“RSU”) and performance restricted stock unit (“PRSU”) awards; and (ii) exercise, and subsequent sale of underlying common stock, of an indeterminable number of stock options. The total number of stock options exercised, and sale of underlying shares of common stock, is dependent on the number of stock options exercised, and sale of underlying shares of common stock, that are ultimately sold under the Exiting Campbell Plan.

(4) Trading under Mr. Clark’s new Rule 10b5-1 Trading Plan may not commence until January 2, 2026, which is after the expiration date of Mr. Clark’s existing Rule 10b5-1 Trading Plan, adopted on March 14, 2025 (the “Existing Clark Plan”), and disclosed in the Company’s Quarterly Report on Form 10-Q for the period ending March 31, 2025.

(5) Mr. Clark’s new Rule 10b5-1 Trading Plan provides for the sale of an indeterminable number of shares of common stock which have been obtained from the vesting of RSU and PRSU awards. The total number of shares of common stock available for sale is dependent on the number of shares that are ultimately sold under the Exiting Clark Plan.

(6) Trading under Ms. Rosenberg’s new Rule 10b5-1 Trading Plan may not commence until January 2, 2026, which is after the expiration date of Ms. Rosenberg’s existing Rule 10b5-1 Trading Plan, adopted on September 10, 2024 (the “Existing Rosenberg Plan”), and disclosed in the Company’s Quarterly Report on Form 10-Q for the period ending September 30, 2024.

(7) Ms. Rosenberg’s new Rule 10b5-1 Trading Plan provides for the exercise, and subsequent sale of underlying common stock, of an indeterminable number of stock options. The total number of stock options exercised, and sale of underlying shares of common stock, is dependent on the number of stock options exercised, and sale of underlying shares of common stock, that are ultimately sold under the Exiting Rosenberg Plan.

(8) Mr. Castelli’s Rule 10b5-1 Trading Plan provides for (i) the exercise of up to 50,000 stock options and the sale of up to 50,000 underlying shares of common stock; and (ii) the sale of 26,158 shares of common stock which have been obtained from the vesting of RSU and PRSU awards.

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Bradley Campbell [Member]

Trading Arrangements, by Individual

Name

Bradley Campbell

Title

President & Chief Executive Officer